Table 3 Five- and 10-year-period relative survival for patients with CLL in 2009–2011

80.2 (0.8)

82.4 (0.7)

−2.2

0.09

59.5 (1.3)

64.7 (1.1)

−5.2

78.4 (1.0)

81.4 (1.0)

−3.0

0.07

57.4 (1.8)

63.0 (1.5)

−5.6

82.9 (1.1)

84.2 (1.0)

−1.3

0.7

63.6 (1.8)

67.9 (1.6)

−4.3

93.4 (2.5)

91.4 (3.1)

+2.0

0.7

78.4 (4.4)

75.9 (4.6)

+2.5

91.5 (1.6)

95.1 (1.2)

−3.6

0.1

72.9 (2.7)

83.1 (2.1)

−10.2

85.9 (1.3)

88.7 (1.1)

−2.8

0.2

64.9 (1.9)

71.8 (1.8)

−6.9

81.7 (1.2)

83.2 (1.3)

−1.5

0.6

59.4 (1.9)

64.6 (1.9)

−5.2

65.1 (1.9)

69.3 (1.6)

−4.2

0.8

42.6 (3.1)

49.0 (2.4)

−6.4

95.7 (2.5)

90.3 (4.3)

+2.4

0.3

78.2 (5.6)

72.0 (6.0)

+6.2

89.9 (2.1)

94.5 (1.7)

−4.6

0.09

68.8 (3.7)

79.4 (2.8)

−10.6

84.8 (1.7)

86.9 (1.5)

−2.1

0.4

59.1 (2.5)

70.1 (2.2)

−11.0

79.2 (1.6)

81.5 (1.7)

−2.3

0.5

56.7 (2.6)

61.7 (2.5)

−5.0

62.1 (2.7)

69.2 (2.3)

−7.1

0.4

44.6 (4.9)

49.7 (3.5)

−5.1

88.0 (5.9)

92.3 (4.7)

−4.3

0.6

77.5 (7.5)

81.5 (7.1)

−4.0

94.9 (2.2)

96.2 (1.8)

−1.3

0.6

79.3 (4.0)

89.9 (2.9)

−10.6

87.9 (2.0)

91.7 (1.6)

−3.8

0.2

74.1 (2.8)

74.5 (2.9)

−0.4

85.8 (1.7)

86.1 (2.0)

−0.3

0.9

63.8 (2.9)

69.5 (2.9)

−5.7

68.3 (2.6)

69.4 (2.3)

−1.1

0.6

42.8 (4.1)

48.6 (3.2)

−5.8